Back to search

Article

Effectiveness of mRNA COVID-19 vaccines against symptomatic SARS-CoV-2 infections during the Delta variant epidemic in Japan: Vaccine Effectiveness Real-time Surveillance for SARS-CoV-2 (VERSUS)

2022-01-23

Abstract excerpt

<h4>Background</h4> Although high vaccine effectiveness of messenger RNA (mRNA) coronavirus disease 2019 (COVID-19) vaccines was reported in studies in several countries, data is limited from Asian countries, especially against the Delta (B.1.617.2) variant. <h4>Methods</h4> We conducted a multicenter test-negative case-control study in patients aged ≥16 visiting hospitals or clinics with signs or symptoms consist...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
53f4578d-7242-5139-b22d-fc1178c5addd
DOI
10.1101/2022.01.17.22269394
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Effectiveness of mRNA COVID-19 vaccines against symptomatic SARS-CoV-2 infections during the Delta variant epidemic in Japan: Vaccine Effectiveness Real-time Surveillance for SARS-CoV-2 (VERSUS)DOI 10.1101/2022.01.17.22269394
Select a neighboring publication to make it the new centre.